[ad_1]
But Bourla was our choice for all that Pfizer has done in a year where Covid vaccines went mainstream (vaccine was even named word of the year by Merriam-Webster) and helped stabilize America’s economy — and the world’s for that matter.
“Pfizer did a lot of good [for] humanity and we are very, very proud of it,” Bourla said in an interview with CNN Business. “Not only were we able to save so many lives … but we are enjoying high levels of corporate reputation right now. People like us.”
Hoping to get Covid pill approved in early 2022
Pfizer isn’t the only company that has developed a vaccine. But the Big Pharma leader, even more so than its European partner BioNTech (BNTX) or rival vaccine developer Moderna (MRNA), has become synonymous with the fight against Covid.
The Pfizer/BioNTech vaccine was the first approved in the United States for 5- to 11-year old kids. But many parents of even younger children are now waiting to hear about when a vaccine might be approved for babies, toddlers and pre-schoolers.
Bourla said he understands the frustration of parents who are fully vaccinated but cannot get their youngest kids protected.
“We’re working very intensively on that to make sure we can bring a solution for that,” Bourla said.
“We are looking at different doses, well below the doses that have been used [for adults and older kids.] We know that it will be safe. What we are looking to see is if that will protect them by giving the lower dose,” he added.
But Pfizer announced after the interview with CNN Business took place that it is still evaluating whether three smaller doses of its vaccine will be effective for kids under 5 after finding two child-sized doses were not producing the expected immunity in 2- to 5-year-olds.
In addition, Pfizer has developed a pill that could drastically reduce the risk of severe complications, hospitalization and death for people who contract the virus. The Food and Drug Administration announced following the interview with Bourla…
[ad_2]
Source : cnn
